Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Lymphobkastic Leukemia”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Not applicableLooking for participantsNCT07258043
What this trial is testing

Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphobkastic LeukemiaLeukemiaOverall Survival
Hospital General de Mexico 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07503353
What this trial is testing

T-cell Expressing a Novel CD19 Chimeric-Antigen Receptor (SHB-02-CD19) in Patients With CD19-expressing B-cell Malignancies

Who this might be right for
B Cell MalignanciesAcute Lymphobkastic LeukemiaNon-Hodgekin Lymphoma (NHL-both Follicular & Diffuse Large Cell)
Sheba Medical Center 50
Post-approval studies (Phase 4)Study completedNCT02036489
What this trial is testing

Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphobkastic Leukemia
PETHEMA Foundation 107
Not applicableNot Yet RecruitingNCT07356960
What this trial is testing

Evaluation of the Efficacy of Ponatinib in Ph+ ALL in the Real-world

Who this might be right for
Acute Lymphobkastic LeukemiaPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 103
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07162571
What this trial is testing

This is a Phase I/II Interventional, Open-label Treatment Study Designed to Evaluate the Safety and Efficacy of Anti CD 19/22 CAR- T Cells Immunotherapy for Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma.

Who this might be right for
Acute Lymphobkastic LeukemiaB Cell Lymphoma
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology 17
Not applicableStudy completedNCT07330141
What this trial is testing

Optimizing Recovery in Pediatric ALL Survivors: A Training Comparison

Who this might be right for
Acute Lymphobkastic Leukemia
Cairo University 72
Testing effectiveness (Phase 2)Temporarily pausedNCT06985498
What this trial is testing

Immunotherapy Combined With Auto-HSCT and CD22/CD19 CAR-T Sandwich Strategy for B-ALL

Who this might be right for
Acute Lymphobkastic Leukemia
The First Affiliated Hospital of Soochow University 40
Not applicableLooking for participantsNCT06600659
What this trial is testing

Determine Number of Patients Who Develop High Ammonia Levels After Receiving Recombinant Erwinia Asparaginase

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmAcute Lymphobkastic Leukemia
Mayo Clinic 10
Not applicableNot Yet RecruitingNCT07245251
What this trial is testing

To Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of STR-P004

Who this might be right for
Acute Lymphobkastic Leukemia
Starna Therapeutics 11
Testing effectiveness (Phase 2)Looking for participantsNCT07039877
What this trial is testing

Efficacy of Low-dose Venetoclax With Itraconazole + TACL for R/R ALL Patients

Who this might be right for
Acute Lymphobkastic LeukemiaAcute Lymphoblastic Leukaemia RecurrentPhiladelphia Chromosome Negative ALL
Hospital Universitario Dr. Jose E. Gonzalez 12